Approval · Notice of Compliance 9233 · 2007
GAMMAGARD S/D: Notice of Compliance 9233
Issued December 7, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9233
- Date
- December 7, 2007
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Replacement therapy for immunodeficiencies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GAMMAGARD S/D | Not yet assigned | — |
Medicinal ingredients
- IMMUNOGLOBULIN (HUMAN) 0.5 G per VIAL
- IMMUNOGLOBULIN (HUMAN) 2.5 G per VIAL
- IMMUNOGLOBULIN (HUMAN) 5 G per VIAL
- IMMUNOGLOBULIN (HUMAN) 10 G per VIAL